REYON Pharmaceutical Co., Ltd. (102460.KS) KSC

11,060.00

+10(+0.09%)

Updated at October 20 10:06AM

Currency In KRW

Valuation

Market Cap235.5B
Enterprise Value429.34B
P/E Ratio-20.38
PEG Ratio0.06
Price/Sales Ratio1.35
Price/Book Ratio0.84
Enterprise/Revenue2.68
Enterprise/EBITDA20.66

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.07
Operating Margin-0.11

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.04

Income Statement

Revenue148.3B
Revenue/Share8,332.61
Gross Profit72.79B
EBITDA12.76B
Net Income4.15B
Diluted EPS226

Balance Sheet

Total Cash8.64B
Total Cash/Share479.86
Total Debt208.85B
Total Debt/Equity0.88
Current Ratio0.61
Book Value Per Share13,158.98

Price History

52-Week Change-33.11
52-Week High18,650
52-Week Low9,830
Moving Average 50 Days11,335.2
Moving Average 200 Days11,721.85

Statistics

Average Volume20,119
Shares Outstanding18.34M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate150
Trailing Annual Dividend Yield1.36
Payout Ratio0
Last Split Factor51:50
Last Split DateDecember 29, 2020